0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query la merie publishing competitor analysis complement c5 inhibitors 2017 biosuperiors biosimilars.Your search for "" gave back 1504468 results.
This report describes and evaluates the competitive landscape of CD22-targeted immunotherapeutics based on different treatment modalities. In B-cell...
Catalog:
La Merie Publishing
November 2016
Price: USD 784.00
The Competitive Intelligence Report Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists as of August 2014 provides a competitor analysis in the...
Catalog:
La Merie Publishing
August 2014
Price: USD 469.00
Report Package: Hot targets for empowered antibody and cell therapy technologies This package contains three reports analyzing BCMA, CD123 and CD22...
Catalog:
La Merie Publishing
December 2016
Price: USD 1,254.00
According to our Publisher latest study, the global Fibroblast Activation Protein Inhibitors market size was valued at USD million in 2022 and is...
Catalog:
GIR
February 2023
Price: USD 3,480.00
This report bundle includes four reports about novel cancer targets which have in common a compelling target expression profile with a low risk of on...
Catalog:
La Merie Publishing
July 2022
Price: USD 2,000.00
Europe biosimilars market was valued at $5,847.6 million in 2020 and will grow by 23.1% annually over 2020-2030 owing to the affordability of...
Catalog:
Grace Market Data
November 2021
Price: USD 2,700.00
North America biosimilars market is expected to grow by 25.1% annually in the forecast period and reach $27.57 billion by 2030 driven by the...
Catalog:
Grace Market Data
November 2021
Price: USD 2,700.00
Asia Pacific biosimilars market will grow by 30.7% annually with a total addressable market cap of $140.4 billion over 2021-2030 owing to the...
Catalog:
Grace Market Data
November 2021
Price: USD 2,700.00
Novel Prophylactic and Therapeutic Approaches to Manage Staphylococcus aureus (S. aureus) Infections Staphylococcus aureus disease is the leading...
Catalog:
La Merie Publishing
October 2013
Price: USD 662.00
CD123: a paradigmatic target for immunotherapeutic treatment modalities This report describes and evaluates the competitive landscape of CD123-...
Catalog:
La Merie Publishing
August 2016
Price: USD 800.00
Global biosimilars market will reach $113.25 billion by 2030, growing by 25.7% annually over 2020-2030 driven by the affordability of biosimilar-...
Catalog:
Grace Market Data
November 2021
Price: USD 3,200.00
RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation,...
Catalog:
La Merie Publishing
November 2022
Price: USD 2,500.00
According to our publisher latest study, the global C5 Fraction market size was valued at USD million in 2022 and is forecast to a readjusted size of...
Catalog:
GIR
March 2023
Price: USD 3,480.00
A generic drug is a pharmaceutical product, usually intended to be interchangeable with an innovator product, that is manufactured without a license...
Catalog:
Signals and Systems Telecom
February 2015
Price: USD 2,500.00
The present Competitive Intelligence report about Cancer Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic...
Catalog:
La Merie Publishing
March 2014
Price: USD 1,112.00
